Breaking News, Collaborations & Alliances

MaSTherCell and Iovance Form Mfg. Agreement

MaSTherCell will make TIL for Iovance’s European late-stage clinical trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Iovance Biotherapeutics has partnered with cell therapy contract development and manufacturing organization (CDMO) MaSTherCell S.A., a subsidiary of Orgenesis Inc. through Masthercell Global Inc. According to the new three-year Manufacturing Services Agreement, MaSTherCell will manufacture TIL for Iovance’s European late-stage clinical trials in its commercial-ready cGMP manufacturing suites.   “We are pleased to be expanding our clinical and manufacturing capacity in Europe through this new c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters